Gosset Ownership
Private
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
SnapCyte Solutions General Information
SnapCyte Solutions has developed and commercialized an AI-powered platform for automated, accurate, and accessible image-based analysis of cell cultures. Their technology enables real-time assessment of cell confluency, growth, fitness, migration, and morphology using smartphone applications integrated with proprietary deep learning models. The platform is designed to be low-cost and user-friendly for life science researchers without requiring coding or advanced AI expertise
Contact Information
Website
Primary Industry
Drug Discovery Services
Corporate Office
Vancouver, British Columbia
Canada
Canada
Drug Pipeline
No pipeline data available
Key Partnerships
Mitacs, Entrepreneurship@UBC, Collaborations with leading academic institutions including University of British Columbia
SnapCyte Solutions Funding
No funding data available
To view SnapCyte Solutions's complete valuation and funding history, request access »